THE TAPE
NHP · REITs · $416.2M

National Healthcare Properties, Inc. Common Stock

$14.65▼ −2.59%
Last close
Relative strength
—RS
Not ranked yet
Caution
−0.1%
six months against REITs
145-session range
−16.1%
from the high
$11.25$17.46
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
86 days
Feb 10 · not confirmed
Growth FLATProof SHOWN
Quarter to Sep 30, revenue +20% on a year ago
Why it is on no screen

NHP passes every check below but is not on a screen — the screens also require the base to be the most recent structure, which this one is not.

A base has formed14.2 weeks, from 14.30 to 17.46.
Long enough to count14.2 weeks against 3 needed.
Shallow enough18.1% deep against 35% allowed.
Close to its pivot-16.1% from the pivot; listed down to -20%.
Relative strengthNot ranked yet — too little history.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter

No 200-day line: this stock has under a year of daily history.

Support and resistance
Support below
$14.38
-1.8% · tested 7× · last 12 sessions ago
Resistance above
$15.14
+3.3% · tested 7× · last 26 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

National Healthcare Properties, Inc. Common Stock is not on any of the screens right now. Its relative strength rating is not ranked yet, and it sits in REITs.

Against its industry
CautionBehind its industry over all three, in an industry that is not ahead of the S&P 500.
One month against its industry
-5.9%
Three months against its industry
-6.6%
Six months against its industry
-0.1%

Read against an equal-weighted index of REITs, which is -2.6% against the S&P 500 over six months Not aligned.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap
86
days
Earnings in 86 days (not yet confirmed)
Feb 10, 2027
  1. Earningstentativein 86d
    Quarterly earnings
    Feb 10, 2027
How it moves on earnings

On average 5.0% either way across its last 2 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$361.4M
+19.8% year on year
Operating margin
11.2%
gross 36.5%
Net margin
-3.4%
Free cash flow
$56.3M
13.5% of market cap
Price to sales
1.15×
Price to earnings
—
not meaningful on a loss

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Nov 4
Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$103.1M
+17.7% QoQ · +19.8% YoY
Gross margin
32.5%
-5.7 pts QoQ
Net income
$20.2M
Positive
Free cash flow
$15.7M
Cash generating

What the numbers say

  • Revenue +19.8% year over year, +17.7% on the quarter
  • Weak: Gross margin 32.5%, -5.7 points on the quarter
  • Good: Profitable: net income $20M, operating margin 30.9%
  • Good: Cash generating: operating cash flow $16M, free cash flow $16M
  • Weak: Share count +156.7% in a year: dilution
  • Good: Net cash $125M · cash $125M
Revenue by quarter
Free cash flow
Net income
shares +156.7% in a year · net cash $125.1M

What is not obvious

  • Margin quality: depreciation and amortisation $24M is 24% of revenue; gross margin 32.5% reads 8.8% if it is charged there
Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is gross margin: gross margin 32.5%, -5.7 points on the quarter.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

None of the tracked funds held or sold it in their latest filings.

Flagged by the market sweep
Reported resultsFiling · 2026-11-05
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Closed below its 20- and 50-day on heavy volumeTape · 2026-10-28
below 20d & 50d on 2.1x volume at 14.88
No measurable effect: stocks behave like random ones over the next three sessions (1,780 cases over 60 nights).
GappedTape · 2026-10-22
+7.1%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Unusual volumeTape · 2026-10-21
5.0 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
GappedTape · 2026-10-15
-5.4%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Entered a material agreementFiling · 2026-09-30
1.01
No measurable effect: stocks behave like random ones over the next three sessions (866 cases over 54 nights).
Unusual volumeTape · 2026-09-19
6.3 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
A director or officer changedFiling · 2026-09-15
5.02
No measurable effect: stocks behave like random ones over the next three sessions (1,288 cases over 54 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
National Healthcare Properties Head of Senior Housing Named to ASHA Executive BoardGlobeNewswire Inc. · 2026-10-21

Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.

Insiders

Nobody bought or sold on the open market in the last 6 months. There were 2 filings for awards, option exercises or shares withheld to pay tax — those happen on a vesting schedule, so they are not a decision to buy or sell.

Most recent filings
2026-09-27 Anderson Michael Ray · CEO, President & director, Directorwithheld for tax16,041$257,137
2026-08-17 Campbell Albert M III · Directoraward4,693

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What analysts expect
Strong buy1
Buy3
Hold4
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
National Healthcare Properties, Inc. Common Stock (NHP) — The Tape